Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmaton Caplets for mental performance and fatigue in night shift nurses
NCT02199847Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2000
- Primary completion
- Jan 2001
01
Overview
A Phase 2 trial of deanol in circadian rhythm sleep disorder (CRSD), fatigue, sponsored by Boehringer Ingelheim. Started Jun 2000; status: completed.
02
Drugs
deanol
03
Conditions
circadian rhythm sleep disorder (CRSD)fatigue
Beyond the preview
Go deeper on NCT02199847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199847.